André S. Bachmann

3.2k total citations
82 papers, 2.4k citations indexed

About

André S. Bachmann is a scholar working on Molecular Biology, Neurology and Biochemistry. According to data from OpenAlex, André S. Bachmann has authored 82 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Molecular Biology, 19 papers in Neurology and 14 papers in Biochemistry. Recurrent topics in André S. Bachmann's work include Polyamine Metabolism and Applications (29 papers), Ubiquitin and proteasome pathways (19 papers) and Neuroblastoma Research and Treatments (19 papers). André S. Bachmann is often cited by papers focused on Polyamine Metabolism and Applications (29 papers), Ubiquitin and proteasome pathways (19 papers) and Neuroblastoma Research and Treatments (19 papers). André S. Bachmann collaborates with scholars based in United States, Germany and Netherlands. André S. Bachmann's co-authors include Elisabeth Knust, Dirk Geerts, Robert Dudler, Markus Kaiser, Ferdi Grawe, M. Groll, Barbara Schellenberg, Robert Huber, Chad R. Schultz and Martina Schneider and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

André S. Bachmann

80 papers receiving 2.4k citations

Peers

Countries citing papers authored by André S. Bachmann

Since Specialization

Citations

This map shows the geographic impact of André S. Bachmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by André S. Bachmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites André S. Bachmann more than expected).

Fields of papers citing papers by André S. Bachmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by André S. Bachmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by André S. Bachmann. The network helps show where André S. Bachmann may publish in the future.

Co-authorship network of co-authors of André S. Bachmann

This figure shows the co-authorship network connecting the top 25 collaborators of André S. Bachmann. A scholar is included among the top collaborators of André S. Bachmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with André S. Bachmann. André S. Bachmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Monitoring ODC activity and polyamines in Bachmann-Bupp syndrome patient biological samples 2025 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Chad R. Schultz, (unknown), Caleb Bupp, André S. Bachmann	0
2	Design, Synthesis, and Biological Activity of Novel Ornithine Decarboxylase (ODC) Inhibitors 2025 ·Journal of Medicinal Chemistry ·Chad R. Schultz, (unknown), Xiaofeng Zhou, Kelly Suino-Powell, Karsten Melcher, Nuno M. S. Almeida, Angela K. Wilson, Edmund L. Ellsworth, André S. Bachmann	1
3	Bachmann–Bupp syndrome and treatment 2023 ·Developmental Medicine & Child Neurology ·André S. Bachmann, (unknown), (unknown), (unknown), Caleb Bupp	9
4	Repurposing eflornithine to treat a patient with a rare ODC1 gain-of-function variant disease 2021 ·eLife ·Surender Rajasekaran, Caleb Bupp, Mara L. Leimanis, (unknown), Christopher Russell, Joseph Junewick, (unknown), (unknown), (unknown), Bryan M. Wittmann, Jeremy W. Prokop, André S. Bachmann	22
5	Expanding the phenotype: Four new cases and hope for treatment in Bachmann‐Bupp syndrome 2021 ·American Journal of Medical Genetics Part A ·(unknown), (unknown), André S. Bachmann, Surender Rajasekaran, Jeremy W. Prokop, Ruben Kuzniecky, Floris C. Hofstede, Katharina Steindl, Anita Rauch, Mark Lipson, Caleb Bupp	12
6	Gene expression signatures identify paediatric patients with multiple organ dysfunction who require advanced life support in the intensive care unit 2020 ·EBioMedicine ·Rama Shankar, Mara L. Leimanis, (unknown), Ke Liu, Jing Xing, Derek Nedveck, Eric J. Kort, Jeremy W. Prokop, Guoli Zhou, André S. Bachmann, Bin Chen, Surender Rajasekaran	13
7	Harmine, a dual-specificity tyrosine phosphorylation-regulated kinase (DYRK) inhibitor induces caspase-mediated apoptosis in neuroblastoma 2018 ·Cancer Cell International ·(unknown), Chad R. Schultz, Dirk Geerts, André S. Bachmann	42
8	Polyamine synthesis as a target of MYC oncogenes 2018 ·Journal of Biological Chemistry ·André S. Bachmann, Dirk Geerts	111
9	Deoxyhypusine synthase (DHPS) inhibitor GC7 induces p21/Rb-mediated inhibition of tumor cell growth and DHPS expression correlates with poor prognosis in neuroblastoma patients 2014 ·Cellular Oncology ·(unknown), Dirk Geerts, Jan Köster, André S. Bachmann	27
10	DFMO/eflornithine inhibits migration and invasion downstream of MYCN and involves p27Kip1 activity in neuroblastoma 2013 ·International Journal of Oncology ·(unknown), Dirk Geerts, Ingo Lange, Jan Köster, Anthony E. Pegg, David J. Feith, André S. Bachmann	45
11	Syringolin B-inspired proteasome inhibitor analogue TIR-203 exhibits enhanced biological activity in multiple myeloma and neuroblastoma 2011 ·Pharmaceutical Biology ·(unknown), Tannya R. Ibarra‐Rivera, Michael C. Pirrung, André S. Bachmann	14
12	Subcellular distribution and expression of prenylated Rab acceptor 1 domain family, member 2 (PRAF2) in malignant glioma: Influence on cell survival and migration 2010 ·Cancer Science ·Tamás Borsics, Emma Lundberg, Dirk Geerts, (unknown), Jan Köster, Kenneth Wester, André S. Bachmann	21
13	Inhibition of S -adenosylmethionine decarboxylase by inhibitor SAM486A connects polyamine metabolism with p53-Mdm2-Akt/protein kinase B regulation and apoptosis in neuroblastoma 2009 ·Molecular Cancer Therapeutics ·(unknown), Tamás Borsics, David J. Feith, (unknown), Christopher J. Wallick, (unknown), Anthony E. Pegg, André S. Bachmann	26
14	Expression profile of PRAF2 in the human brain and enrichment in synaptic vesicles 2008 ·Neuroscience Letters ·(unknown), (unknown), Kenneth Wester, André S. Bachmann	15
15	Expression of Prenylated Rab Acceptor 1 Domain Family, Member 2 (PRAF2) in Neuroblastoma: Correlation with Clinical Features, Cellular Localization, and Cerulenin-Mediated Apoptosis Regulation 2007 ·Clinical Cancer Research ·Dirk Geerts, Christopher J. Wallick, (unknown), Jan Köster, Rogier Versteeg, (unknown), André S. Bachmann	22
16	Genomic organization, expression profile, and characterization of the new protein PRA1 domain family, member 2 (PRAF2) 2006 ·Gene ·(unknown), (unknown), Christopher J. Wallick, (unknown), André S. Bachmann	29
17	Genomic organization, characterization, and molecular 3D model of GDE1, a novel mammalian glycerophosphoinositol phosphodiesterase 2006 ·Gene ·André S. Bachmann, (unknown), Gábor Mócz	13
18	Key role for p27Kip1, retinoblastoma protein Rb, and MYCN in polyamine inhibitor-induced G1 cell cycle arrest in MYCN-amplified human neuroblastoma cells 2005 ·Oncogene ·Christopher J. Wallick, (unknown), (unknown), David J. Feith, (unknown), Shannon M. Wilson, (unknown), Anthony E. Pegg, Craig V. Byus, André S. Bachmann	78
19	Ciliogenesis: Polarity Proteins on the Move 2004 ·Current Biology ·Olaf Bossinger, André S. Bachmann	10
20	Dissection of cis-regulatory elements of the Drosophila gene Serrate 1998 ·Development Genes and Evolution ·André S. Bachmann, Elisabeth Knust	46

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact